Mirion Technologies MIR Business Segments
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| Total revenues by Business | ||||||
| Medical Segment | $314.3M+4.2% | $310.8M+3.7% | $313.9M+6.3% | $309.5M+6.7% | $301.5M+5.8% | |
| Nuclear & Safety | $666.7M+17.2% | $614.6M+9.5% | $588.4M+12.8% | $576.5M+11.3% | $568.7M+10.8% | |
| Total revenues by Product | ||||||
| Cancer care | $243.4M+5.8% | $239.1M+4.9% | $241.2M+11.7% | $236.3M+11.0% | $230.1M+9.1% | |
| Labs and research | $123.7M-1.4% | $122.2M-7.2% | $124.8M-0.8% | $126.2M+4.2% | $125.5M+0.3% | |
| Other | $112.2M+2.8% | $113M+0.2% | $112.9M+8.6% | $110.1M+6.5% | $109.1M+11.8% | |
| Total revenues by Geography | ||||||
| Asia Pacific | $14.5M+12.4% | $15.6M+20.9% | $14.2M-7.8% | $13.9M-3.5% | $12.9M-13.4% | |
| Europe | $340.1M+12.1% | $327.7M+7.2% | $318.5M+7.3% | $308.1M+6.6% | $303.4M+7.9% | |
| North America | $626.4M+13.1% | $582.1M+7.4% | $569.6M+8.6% | $564M+8.9% | $553.9M+7.5% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How does Mirion Technologies break its business down?
- Mirion Technologies (MIR) reports total revenues by business across 2 parts — Medical Segment and Nuclear & Safety. Each is extracted from the segment footnotes and tracked over time.
- Where does Mirion Technologies's segment data come from?
- Segment breakdowns are pulled from the segment footnotes in Mirion Technologies's SEC filings (the XBRL dimensional tags), so every line ties back to a reported figure. Switch between quarterly, annual, and TTM, or open any segment for its full history.